Nitrogen-doped carbon-coated cuprous oxide hollow nanocapsule as well as preparation method and application thereof
By preparing carbon-coated cuprous oxide hollow nanocapsules, the problems of low stability and catalytic efficiency of copper-based nanomedicines in tumor treatment were solved, and the efficient catalytic generation of hydroxyl radicals in weakly acidic media was achieved, thereby improving the therapeutic effect of tumor treatment.
Patent Information
- Application Number
- CN202411277260.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-26
AI Technical Summary
Existing copper-based nanomedicines exhibit high hydrophobicity, high systemic toxicity, and low biocompatibility in tumor treatment. They are difficult to effectively catalyze the generation of hydroxyl radicals in weakly acidic or neutral media, and the core-shell structure fails to effectively protect nanoparticles from leakage or inactivation due to steric hindrance.
A method for preparing carbon-coated cuprous oxide hollow nanocapsules was adopted, using copper nitrate as the copper source and N,N-dimethylformamide as the solvent and carbon source. Carbon-coated cuprous oxide hollow nanocapsules were formed through hydrothermal reaction, exhibiting unique structure and high stability, and possessing dual catalytic activities of peroxidase and glutathione oxidase.
It achieves efficient catalytic generation of hydroxyl radicals in the tumor microenvironment, consumes glutathione, improves tumor treatment efficiency, and has strong stability, making it suitable for tumor treatment, antibacterial and anti-inflammatory applications, and biological detection.
Smart Images

Figure CN119015260A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of copper-based nanozyme preparation and biomedical technology, and in particular to a nitrogen-doped carbon-coated cuprous oxide hollow nanocapsule with high-efficiency peroxidase-like activity, and a preparation method and application thereof. Background Art
[0002] Cancer has become a major cause of death due to its complex etiology and uncontrollable development process. Among the many cancer treatment strategies currently available, tumor microenvironment-responsive chemodynamic therapy has been widely studied and paid attention to by researchers due to its high specificity and low invasiveness. Chemodynamic therapy based on nanozymes that undergo Fenton reaction or Fenton-like reaction can decompose hydrogen peroxide into hydroxyl radicals (·OH) in hypoxic tumor cells, leading to cell apoptosis and tumor ablation. Traditional chemodynamic therapy mainly relies on Fe 2+ The Fenton reaction is mediated by glutathione, but the reaction can usually be carried out in a strongly acidic environment (pH = 2-4), and the reaction rate is extremely low in the slightly acidic tumor microenvironment. In addition, the overexpression of glutathione in tumor cells will neutralize the highly toxic hydroxyl radicals generated, resulting in reduced therapeutic efficiency. Therefore, the development of multifunctional nanozymes with more efficient catalytic efficiency is of great practical significance.
[0003] With the development of nanotechnology, copper-based nanomedicines have attracted great attention in the field of tumor treatment, mainly due to their physicochemical properties and the biological effects of copper. Copper has two oxidation states under physiological conditions, namely Cu(I) and Cu(II). On the one hand, its inherent redox properties can catalyze the production of ROS, and in weakly acidic or even neutral media, it has shown great potential as a Fenton-like reagent. On the other hand, Cu(II) can bind to glutathione, a reducing substance abundant in tumor cells, and it itself is reduced to Cu(I) to activate the Fenton-like reaction, catalyzing the generation of ·OH while consuming glutathione. However, most copper-based nanomedicines are currently limited by high hydrophobicity, high systemic toxicity and low biocompatibility, making it difficult to achieve clinical application. Therefore, it is very necessary to design a copper-based nanozyme with strong biocompatibility to enhance the chemokinetic efficacy by inhibiting the overexpression of GSH.
[0004] The catalytic efficiency of nanomedicines is closely related to their morphological structure. Previous studies have shown [G. Zhang, et al. CuOdot-decorated Cu@Gd2O3 core-shell hierarchical structure for Cu(Ⅰ) self-supplying chemodynamic therapy in combination with MRI-guided photothermalsynergistic therapy, Mater. Horiz. 2021, 8] that the structure and morphology of copper-based nanomedicines are prone to thiol cleavage in proteins or other macromolecules, resulting in catalytic inactivation and significantly reduced anti-tumor ability, while the core-shell structure can protect the active ingredients in the nanoparticles from leakage or inactivation due to steric hindrance. The Chinese patent application document with publication number CN118185405A discloses a ZnO@Cu2O core-shell antibacterial particle, in which the ZnO shell layer on the surface tightly wraps the Cu2O to form a protective barrier, ensuring the long-lasting and gentle release of copper ions; the Chinese patent application document with publication number CN118268044A discloses a Cu2O / Cu-MOF photothermal catalyst with a close interface contact core-shell structure, which promotes the effective utilization of photogenerated electrons and holes and exhibits more excellent photocatalytic activity. However, these patents do not involve the carbon layer-coated core structure of this patent, nor do they involve its application as a chemodynamic therapeutic agent. Summary of the invention
[0005] The technical problem to be solved by the present invention is how to obtain a nitrogen-doped carbon-coated cuprous oxide hollow nanocapsule with high efficiency peroxidase-like activity and high stability.
[0006] The present invention solves the above technical problems through the following technical means:
[0007] The invention provides a preparation method of carbon-coated cuprous oxide hollow nanocapsules, comprising the following steps: using copper nitrate as a copper source and N,N-dimethylformamide as a solvent and a carbon source to obtain carbon-coated cuprous oxide hollow nanocapsules through hydrothermal reaction; the ratio of the volume of N,N-dimethylformamide to the molar number of copper nitrate is 100 mL: (0.5-1) mmol; and the temperature of the hydrothermal reaction is 180-220° C. and the time is 42 h-50 h.
[0008] Beneficial effects: In the present invention, copper nitrate is used as the copper source, N,N-dimethylformamide is used as the solvent and the carbon source, and the carbon-coated cuprous oxide hollow nanocapsules are obtained by the reaction. The carbon-coated cuprous oxide hollow nanocapsules have a unique structure and strong stability, and have dual catalytic activities of peroxidase and glutathione oxidase, and are an excellent chemodynamic therapeutic agent.
[0009] Preferably, the ratio of the volume of N,N-dimethylformamide to the molar number of copper nitrate is 100 mL:1 mmol.
[0010] Preferably, the copper nitrate is copper nitrate trihydrate, and the usage ratio of the copper nitrate trihydrate to N,N-dimethylformamide is 96.8 mg (0.4 mmol):40 mL.
[0011] Preferably, the temperature of the hydrothermal reaction is 200° C. and the time is 48 hours.
[0012] Preferably, the method further comprises centrifuging, washing and drying the product after the hydrothermal reaction.
[0013] Preferably, the centrifugal speed is 10000-14000 rpm, and the centrifugal time is 8-12 min.
[0014] Preferably, the drying temperature is 50-70° C. and the drying time is 20-26 hours.
[0015] Preferably, the preparation method of the carbon-coated cuprous oxide hollow nanocapsules comprises the following steps: mixing copper nitrate trihydrate and N,N-dimethylformamide in a dosage ratio of 96.8 mg (0.4 mmol): 40 mL to obtain a reaction solution; placing the obtained reaction solution in a hydrothermal reactor, reacting at 200° C. in a vacuum drying oven for 48 hours, cooling to room temperature after the reaction, collecting the reaction solution in the reactor, centrifuging at 12000 rpm for 10 minutes and washing with deionized water for several times until the supernatant becomes colorless; washing the precipitate at the bottom of the test tube with ethanol solution 3 times, placing it in a vacuum drying oven at 60° C. and drying it for 10 hours, and the finally obtained brown-yellow powder is the carbon-coated cuprous oxide hollow nanocapsule.
[0016] The present invention also provides carbon-coated cuprous oxide hollow nanocapsules prepared by the above preparation method.
[0017] The present invention also proposes the use of the carbon-coated cuprous oxide hollow nanocapsules as chemodynamic therapeutic agents.
[0018] The advantages of the present invention are:
[0019] (1) The carbon-coated cuprous oxide hollow nanocapsules prepared by the present invention can be applied to tumor treatment, antibacterial and anti-inflammatory, biological detection and the like.
[0020] (2) Compared with other cuprous oxide nanoparticles, the unique hollow structure of the cuprous oxide nanocapsules synthesized in the present invention has more active sites, and the surface carbon layer can effectively protect Cu +It is not oxidized, which improves the stability of the nanocapsules and greatly enhances the efficiency of tumor treatment.
[0021] (3) Compared with other methods, the raw materials used in the present invention are low in cost, safe, mild in synthesis conditions, simple in synthesis steps, and can synthesize a large amount of carbon-coated cuprous oxide nanocapsules in a short period of time, which has great prospects for application in large-scale industrial manufacturing in the future.
[0022] (4) The nanocapsules have excellent dual activities of peroxidase and glutathione oxidase, which can convert excess hydrogen peroxide in triple-negative breast cancer cells into toxic hydroxyl free radicals to kill cancer cells. At the same time, they consume overexpressed glutathione in the cells, hindering the loss of effective killing substances, and ultimately achieving efficient catalytic treatment of tumors. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The scanning electron microscope characterization of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention (the inset is a scanning electron microscope image of a single nanocapsule);
[0024] Figure 2 This is a statistical diagram of particle size distribution of carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0025] Figure 3 Transmission electron microscopy characterization of carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention (the inset is a magnified transmission electron microscopy image of a single nanocapsule);
[0026] Figure 4 This is a high-resolution transmission electron microscope image of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0027] Figure 5 This is a selective area electron diffraction image of the sample of Example 1 of the present invention;
[0028] Figure 6 The energy dispersive X-ray mapping image and HAADF spectrum of the sample in Example 1 of the present invention;
[0029] Figure 7 This is an X-ray diffraction image of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0030] Figure 8 This is the Raman spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0031] Fig. 9 This is an X-ray diffraction image of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention exposed to air for a long period of time;
[0032] Fig.10 is the infrared spectrum of the cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0033] Fig.11 is the long-period particle size stability of the cuprous oxide hollow nanocapsules in Example 1 of the present invention measured by dynamic light scattering;
[0034] Fig.12 This is the apparent Zeta potential distribution diagram of the cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0035] Fig.13 is the specific surface area of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention ( Fig.13 a) and pore size ( Fig.13 b) Figure;
[0036] Fig.14 is the X-ray photoelectron spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0037] Fig.15 This is the X-ray photoelectron spectrum C1s spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0038] Fig.16 It is the X-ray photoelectron spectrum N1s spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0039] Fig.17 The X-ray photoelectron spectrum O1s spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0040] Fig.18 is the X-ray photoelectron spectroscopy Cu 2p spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0041] Fig.19 The in vitro glutathione oxidase-like activity test of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0042] Fig. 20 This is the in vitro peroxidase-like activity test of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention. Fig. 20 a is the ultraviolet absorption spectrum of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 after reacting with TMB and hydrogen peroxide for 5 minutes under different pH values (pH 5.0 and pH 7.4); Fig. 20 b is the enzyme rate of the sample of Example 1 at different TMB concentrations fitted by the Michaelis-Menten equation;
[0043] Fig.21 The cell viability of 4T1 cells treated with the carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention under different pH conditions (pH=7.4, 6.2, 5.0);
[0044] Fig. 22 Schematic diagram of the synthesis principle of carbon-coated cuprous oxide hollow nanocapsules in Example 1 of the present invention;
[0045] Fig.23 Transmission electron microscopy characterization of the solid cuprous oxide catalyst in Comparative Example 1 of the present invention;
[0046] Fig.24 This is an X-ray diffraction image of the solid cuprous oxide catalyst in Comparative Example 1 of the present invention;
[0047] Fig.25 Transmission electron microscopy characterization of the copper-based catalyst in Comparative Example 2 of the present invention;
[0048] Fig.26 is an X-ray diffraction image of the copper-based catalyst in Comparative Example 2 of the present invention;
[0049] Fig. 27 Transmission electron microscopy characterization of the copper-based catalyst in Comparative Example 3 of the present invention;
[0050] Fig.28 This is the X-ray diffraction image of the copper-based catalyst in Comparative Example 3 of the present invention. DETAILED DESCRIPTION
[0051] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described in combination with the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0052] Unless otherwise specified, the test materials and reagents used in the following examples can be obtained from commercial sources.
[0053] If no specific techniques or conditions are specified in the examples, they can be carried out according to the techniques or conditions described in the literature in the art or according to the product instructions.
[0054] Embodiment 1:
[0055] A method for preparing carbon-coated cuprous oxide hollow nanocapsules comprises the following steps:
[0056] Step 1: Add 96.8 mg (0.4 mmol) of copper nitrate trihydrate and 40 mL of N,N-dimethylformamide into a beaker, and sonicate the resulting mixture for 15 minutes to ensure thorough mixing.
[0057] Step 2: The mixed solution was transferred to a 50 mL Teflon hydrothermal reactor and subjected to hydrothermal reaction at 200° C. for 48 hours in a vacuum drying oven. After completion, the mixture was allowed to cool naturally to room temperature.
[0058] Step 3: Collect the reaction solution and centrifuge at 12000 rpm for 10 minutes. Wash with deionized water several times until the supernatant is colorless. Then wash the precipitate with ethanol solution 3 times.
[0059] Step 4: Place the washed precipitate in a vacuum drying oven and dry it at 60° C. for 24 hours to obtain the final yellow-brown powder, which is the carbon-coated cuprous oxide hollow nanocapsules.
[0060] Embodiment 2:
[0061] A method for preparing carbon-coated cuprous oxide hollow nanocapsules comprises the following steps:
[0062] Step 1: Add 0.2 mmol of copper nitrate trihydrate and 40 mL of N,N-dimethylformamide into a beaker and sonicate the resulting mixture for 15 minutes to ensure thorough mixing.
[0063] Step 2: The mixed solution was transferred to a 50 mL Teflon hydrothermal reactor and subjected to hydrothermal reaction at 220° C. for 45 hours in a vacuum drying oven. After completion, the mixture was allowed to cool naturally to room temperature.
[0064] Step 3: Collect the reaction solution and centrifuge at 10000 rpm for 12 minutes. Wash with deionized water several times until the supernatant is colorless. Then wash the precipitate with ethanol solution 3 times.
[0065] Step 4: The washed precipitate is placed in a vacuum drying oven and dried at 50° C. for 26 hours to obtain the final yellow-brown powder, which is the carbon-coated cuprous oxide hollow nanocapsules.
[0066] Embodiment 3:
[0067] A method for preparing carbon-coated cuprous oxide hollow nanocapsules comprises the following steps:
[0068] Step 1: Add 0.3 mmol of copper nitrate trihydrate and 40 mL of N,N-dimethylformamide into a beaker, and ultrasonicate the resulting mixture for 15 minutes to ensure thorough mixing.
[0069] Step 2: The mixed solution was transferred to a 50 mL Teflon hydrothermal reactor and subjected to hydrothermal reaction at 180° C. for 50 hours in a vacuum drying oven. After completion, the mixture was allowed to cool naturally to room temperature.
[0070] Step 3: Collect the reaction solution and centrifuge at 14000 rpm for 8 minutes. Wash with deionized water several times until the supernatant is colorless. Then wash the precipitate with ethanol solution 3 times.
[0071] Step 4: The washed precipitate is placed in a vacuum drying oven and dried at 70° C. for 20 hours to obtain the final yellow-brown powder, which is the carbon-coated cuprous oxide hollow nanocapsules.
[0072] Comparative Example 1: Preparation of Carbon-coated Cuprous Oxide Solid Nanocapsules
[0073] The difference between this comparative example and Example 1 is that the reaction time in step 2 is 20 hours.
[0074] The product obtained in this comparative example has a morphological characterization diagram as shown in Fig.23 Its X-ray diffraction pattern is shown in Fig.24 shown.
[0075] Comparative Example 2: Preparation of Carbon-Coated Polymorphic Copper-Based Catalyst
[0076] The difference between this comparative example and Example 1 is that the reaction time in step 2 is 56 hours.
[0077] The product obtained in this comparative example has a morphological characterization diagram as shown in Fig.25 Its X-ray diffraction pattern is shown in Fig.26 shown.
[0078] Comparative Example 3: Preparation of Carbon-Coated Polymorphic Copper-Based Catalyst
[0079] The difference between this comparative example and Example 1 is that the reaction time in step 2 is 60 hours.
[0080] The product obtained in this comparative example has a morphological characterization diagram as shown in Fig. 27 Its X-ray diffraction pattern is shown in Fig.28 shown.
[0081] First, the morphology of the carbon-coated cuprous oxide hollow nanocapsules prepared in Example 1 was characterized. Figure 1 As shown, the sample observed by scanning electron microscopy appears to be a uniform spherical shape, and the image of a single nanocapsule in the inset confirms the existence of a hollow structure.
[0082] Figure 2 For Figure 1On the basis of the particle size distribution of the sample of Example 1 obtained by statistical Gaussian fitting distribution analysis, the average size distribution of the nanocapsules is 130 nm.
[0083] like Figure 3 As shown, the sample in Example 1 was characterized by transmission electron microscopy, and it can be clearly observed that the cuprous oxide hollow nanocapsules in Example 1 are composed of many nanocrystals with a size of about 16 nm.
[0084] like Figure 4 As shown, the high-resolution transmission electron microscope image shows a clear lattice fringe of 0.246 nm, corresponding to the (111) crystal plane of cuprous oxide. In addition, a carbon film with a thickness of 1.88 nm can be observed, confirming that the surface of the cuprous oxide hollow nanocapsules in Example 1 is covered with a carbon layer.
[0085] exist Figure 5 Several obvious electron diffraction rings are shown in the figure, corresponding to the (311), (200), (110), (111) and (220) crystal planes of cuprous oxide.
[0086] like Figure 6 As shown, energy dispersive X-ray mapping and HAADF image analysis were performed on the cuprous oxide hollow nanocapsules of single Example 1, proving the presence of Cu, C, O and N elements therein.
[0087] The X-ray diffraction pattern of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 is as follows: Figure 7 As shown, the characteristic diffraction peaks of cuprous oxide are clearly shown. Specifically, the peaks at 29.88°, 36.80°, 42.59°, 61.74° and 73.87° correspond to the (110), (111), (200), (220) and (311) crystal planes of cuprous oxide, respectively.
[0088] like Figure 8 As shown in the Raman spectrum, a peak at 1350 cm -1 and 1570cm -1 The obvious D peak and G peak at come from the carbon layer wrapped on the surface of cuprous oxide.
[0089] Example 1 The X-ray diffraction patterns of the samples exposed to air for different days are as follows Fig. 9 As shown, all characteristic peaks of cuprous oxide are present, indicating that the presence of the surface carbon layer protects cuprous oxide from oxidation.
[0090] like Fig.10As shown in the figure, the infrared test of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 was performed using a Fourier infrared spectrometer. The absorption peak positions of different wavelengths in the figure represent the different functional group bond positions. -1 The peak position represents the stretching vibration of OH and NH, 1633 cm -1 The peak positions represent CC bending vibrations.
[0091] The hydration kinetics particle size measurement results of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 over a 30-day period are as follows: Fig.11 As shown in the figure, the material size did not change significantly during the cycle. This indicates that the sample maintained good dispersion for a long time without significant agglomeration, thus proving its excellent stability.
[0092] like Fig.12 As shown, the carbon-coated cuprous oxide hollow nanocapsules in Example 1 have an apparent Zeta potential of -36.7 mV, demonstrating that they have good physical stability.
[0093] like Fig.13 As shown, the specific surface area of the nanocapsules in Example 1 is 33.846 m 2 / g( Fig.13 a), the average pore sizes are 3.28nm, 3.81nm and 4.88nm respectively ( Fig.13 b).
[0094] The X-ray photoelectron spectrum of the carbon-coated cuprous oxide hollow nanocapsules obtained in Example 1 is as follows: Fig.14 The signal shows that the C atom content is 24.67%, the Cu content is 32.58%, the N content is 3.38%, and the O content is 39.37%.
[0095] The C1s, N 1s, O 1s and Cu2p spectra of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 are as follows: Figure 15-18 As shown, the bond positions represented by the corresponding characteristic peaks are marked in the picture.
[0096] Example 1 The glutathione oxidase-like activity of the sample is as follows Fig.19 As shown, the conversion process of reduced glutathione (GSH) to oxidized glutathione (GSSG) during a reaction time was monitored by nuclear magnetic resonance hydrogen spectrum. As the reaction time increases, the characteristic peak signal intensity of GSH in the spectrum gradually decreases, while the characteristic peak signal intensity of GSSG gradually increases, indicating that the sample in Example 1 has glutathione oxidase-like activity and can convert GSH into GSSG.
[0097] like Fig. 20As shown, the reaction ability of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 to hydroxyl radicals was evaluated using 3,3',5,5'-tetramethylbenzidine (TMB) as a calibrant (i.e., under the action of active oxygen, TMB was oxidized to oxTMB, which exhibited a characteristic absorption peak of 651 nm in the ultraviolet absorption spectrum and turned the solution blue). Fig. 20 a is the ultraviolet absorption spectra of the carbon-coated cuprous oxide hollow nanocapsules in Example 1 after reacting with TMB and hydrogen peroxide for 5 minutes under different pH values (pH 5.0 and pH 7.4). The absorption peak intensity at 651 nm increases with decreasing pH, and the color of the solution also turns dark blue with decreasing pH ( Fig. 20 a, from left to right are the colors of the reactants of the sample of Example 1 after reacting for 5 min under pH 7.4 and pH 5.0 conditions, respectively), which indicates that Example 1 exhibits significant peroxidase-like activity in an acidic environment. Fig. 20 b is the enzyme rate Vmax (0.2458 μM / s) of the sample of Example 1 at different TMB concentrations fitted by the Michaelis-Menten equation, indicating that Example 1 has excellent peroxidase-like catalytic efficiency.
[0098] The results of the 4T1 tumor cell killing experiment conducted at the cellular level under different pH conditions are as follows: Fig.21 As shown. Under the conditions of pH 5.0 and pH 6.2 (simulating tumor microenvironment), the cuprous oxide nanocapsules in Example 1 showed obvious cell killing effect. Under the specific conditions of pH 5.0 and 100 μg / mL, the sample showed a cell killing rate of up to 93%.
[0099] Figure 19-21 The specific experimental methods are as follows:
[0100] Determination of GSH consumption: 10 mL of the sample solution (2 mg / mL) of Example 1 and 10 mL of GSH solution (20 mM) were mixed and stirred for different reaction times. After centrifugation at 12000 rpm for 5 min, 0.5 mL of the supernatant and 0.05 mL of D2O were taken for NMR detection. The characteristic peak intensities of GSH and GSSG in the spectra at different time periods were compared to obtain Fig.19 .
[0101] · OH generation rate detection: First, 150 μL TMB solution (0.694 mM, dissolved in DMSO) and 20 μg of cuprous oxide nanocapsules in Example 1 were added to a cuvette containing 3.0 mL acetic acid-sodium acetate buffer solution (pH 5.0, 6.2 or 7.4). Then, 150 μL of H2O2 (30 wt%) solution was added. After 5 minutes, the solution in the cuvette was scanned by ultraviolet absorption spectrum to record the 651 nm characteristic peak intensity, and the color change of the cuvette solution was recorded by taking a photo. The above steps yielded Fig. 20 Left picture.
[0102] Peroxidase rate V max Determination: With H2O2 as the substrate, the catalytic rate of the cuprous oxide nanocapsules in Example 1 was calculated by adjusting (controlling the variables) the amount of the sample in Example 1, TMB and H2O2 in the above operation. In the experiment, the colorimetric response was measured at 651 nm by ultraviolet absorption spectroscopy every 10 seconds. The absorption value data was then imported into Origin2020 software and fitted using the Michaelis-Menten equation to determine the peroxidase rate Vmax of the sample in Example 1, i.e. Fig. 20 Right picture.
[0103] Cell-level chemical kinetics detection and in vitro cell viability test: 4T1 cells were distributed into 96-well plates with a cell density of 3.5×10 per well. 3 , incubated in a 37°C 5% CO2 incubator for 24 h. The cells were then incubated with PBS solutions containing cuprous oxide nanocapsules at different concentrations (0, 12.5, 25, 50 and 100 μg / mL) at three different pH conditions (pH 5.0, pH 6.2 and pH 7.4) for 24 h. Cell viability was assessed by cell titer-fluorescence method, and the fluorescence intensity was detected by Envision Perkin Elmer multi-label plate reader. Fig.21 .
[0104] The morphology and performance of the carbon-coated cuprous oxide hollow nanocapsules prepared in Examples 2 and 3 are similar to those in Example 1.
[0105] The carbon-coated cuprous oxide hollow nanocapsules obtained by the present invention are prepared by reacting copper nitrate and N,N-dimethylformamide, and the schematic diagram thereof is shown in FIG. Fig. 22 As shown, its unique morphology has a structure-guided and more efficient chemokinetic tumor treatment effect.
[0106] Comparative Example 1 synthesized cuprous oxide solid nanocapsules with the same raw material ratio but with the reaction time shortened to 20 hours. Fig.23 This is the transmission electron microscope image of comparative example 1. The hollow cavity of the sample disappears and turns into a solid spherical structure. Fig.24 The X-ray diffraction spectrum of Comparative Example 1 still shows characteristic peaks of cuprous oxide, that is, the peaks of 2θ at 29.88°, 36.80°, 42.59°, 61.74° and 73.87° correspond to the (110), (111), (200), (220) and (311) crystal planes of cuprous oxide, respectively. This indicates that Comparative Example 1 synthesized a catalyst with a different morphology from Example 1 but the same crystal form.
[0107] Comparative Example 2 synthesized a polymorphic copper-based catalyst with the same raw material ratio but with the reaction time extended to 56 hours. Fig.25 This is the transmission electron microscope image of comparative example 2. The cavity structure of the sample has been damaged to a certain extent, and the carbon layer on the surface has become thinner. Fig.26 The X-ray diffraction spectrum of Comparative Example 2 shows that in addition to the characteristic peaks of cuprous oxide, characteristic diffraction peaks of copper also appear. Specifically, the peaks at 43.3° and 50.4° of 2θ correspond to the (111) and (200) crystal planes of copper, respectively. This indicates that the catalyst synthesized in Comparative Example 2 has a different morphology from that of Example 1 and a changed crystal form.
[0108] Comparative Example 3 synthesized a polymorphic copper-based catalyst with the same raw material ratio but with the reaction time extended to 60 hours. Fig. 27 This is the transmission electron microscope image of comparative example 3. The cavity structure and surface carbon layer of the sample no longer exist, and large black patches are present. Fig.28 This is the X-ray diffraction spectrum of Comparative Example 3. The characteristic peak signal of cuprous oxide is very weak, and the characteristic peak of copper is mainly shown. Specifically, the peaks of 2θ at 43.3°, 50.4° and 74.1° correspond to the (111), (200) and (220) crystal planes of copper, respectively. This indicates that the catalyst synthesized in Comparative Example 2 has a great change in morphology and crystal form compared with Example 1.
[0109] The above data fully demonstrate the necessity of appropriate reaction time for obtaining carbon-coated cuprous oxide hollow nanocapsules.
[0110] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for preparing carbon-coated cuprous oxide hollow nanocapsules, characterized in that: Copper nitrate is used as a copper source, N,N-dimethylformamide is used as a solvent and a carbon source, and carbon-coated cuprous oxide hollow nanocapsules are obtained through a hydrothermal reaction; the ratio of the volume of N,N-dimethylformamide to the molar number of copper nitrate is 100 mL: 0.5-1 mmol; the temperature of the hydrothermal reaction is 180-220° C., and the time is 42 h-50 h.
2. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 1, characterized in that: The ratio of the volume of N,N-dimethylformamide to the molar number of copper nitrate is 100 mL:1 mmol.
3. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 1, characterized in that: The copper nitrate is copper nitrate trihydrate, and the usage ratio of the copper nitrate trihydrate to N,N-dimethylformamide is 0.4mmol:40mL.
4. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 1, characterized in that: The temperature of the hydrothermal reaction is 200° C. and the time is 48 hours.
5. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to any one of claims 1 to 4, characterized in that: The method also includes centrifuging, washing and drying the product after the hydrothermal reaction.
6. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 5, characterized in that: The centrifugal speed is 10000-14000 rpm, and the centrifugal time is 8-12 min.
7. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 5, characterized in that: The drying temperature is 50-70°C and the drying time is 20-26h.
8. The method for preparing carbon-coated cuprous oxide hollow nanocapsules according to claim 5, characterized in that: The following steps are involved: Copper nitrate trihydrate and N,N-dimethylformamide are mixed in a dosage ratio of 0.4mmol:40mL to obtain a reaction solution; the obtained reaction solution is placed in a hydrothermal reactor, and reacted at 200°C in a vacuum drying oven for 48 hours. After the reaction is completed, the reaction solution is cooled to room temperature, and the reaction solution in the reactor is collected, centrifuged at 12000rpm for 10 minutes, and washed several times with a deionized water solution until the supernatant is colorless; the precipitate at the bottom of the test tube is washed 3 times with an ethanol solution, and placed in a vacuum drying oven at 60°C for 10 hours. The brown-yellow powder finally obtained is the carbon-coated cuprous oxide hollow nanocapsule.
9. Carbon-coated cuprous oxide hollow nanocapsules prepared by the preparation method according to any one of claims 1 to 8.
10. Use of the carbon-coated cuprous oxide hollow nanocapsules according to claim 9 as a chemodynamic therapy agent.
